Atypical Hemolytic Uremic Syndrome - 18 Studies Found
| Completed |
: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome : Atypical Hemolytic-Uremic Syndrome : 2010-08-31 : Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
| Completed |
: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome : Atypical Hemolytic-Uremic Syndrome : 2010-08-31 : Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient |
| Completed |
: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) : Atypical Hemolytic Uremic Syndrome : 2009-02-03 : Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
| Completed |
: Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease : Atypical Hemolytic Uraemic Syndrome. : 2009-06-29 |
| Not yet recruiting |
: Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) : Atypical Hemolytic Uremic Syndrome (aHUS) : 2017-04-24 : Biological: ALXN1210 Single loading dose on Day 1, followed by regular maintenance dosing beginning on D |
| Completed |
: A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) : Atypical Hemolytic Uremic Syndrome (aHUS) : 2012-11-13 |
| Recruiting |
: Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS : Atypical Hemolytic Uremic Syndrome : 2015-10-05 : Drug: eculizumab eculizumab discontinuation |
| Terminated |
: aHUS Observational Long Term Follow-Up : Atypical Hemolytic Uremic Syndrome : 2012-01-18 |
| Recruiting |
: Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry : Atypical Hemolytic-Uremic Syndrome : 2012-01-18 |
| Terminated |
: Complement Inhibition in aHUS Dialysis Patients : Atypical Hemolytic Uremic Syndrome : 2015-05-26 : Drug: CCX168 |